News & Events
August 15, 2019
Launching your biotech start-up is an exciting, albeit overwhelming, venture. Eager entrepreneurs often struggle to navigate the labyrinth of tasks necessary to getting a startup off the […]
July 29, 2019
CAFC Rules Suboxone Patent is Not Infringed by Generic Buprenorphine Film Product By: Katie Rubino Recently on July 9th the Court of Appeals for […]
July 24, 2019
Patent Attorney John Gillis Joins Caldwell IP Law Boston Team By: Lindsey Powell Caldwell IP Law is pleased to announce that John Gillis has […]
July 8, 2019
Patent Strategies for Small Molecule Drugs Versus Biological Drugs By: Katie Rubino Molecules used as drug products are often categorized into two classes: small […]
June 11, 2019
CAFC Affirms Invalidation of Oxycodone Patent for Lack of Written Description By: Katie Rubino On April 19th, 2019 the Court of Appeals of the Federal […]
May 28, 2019
Supreme Court Denies Certiorari Petition on Tribal Sovereign Immunity in IPR Proceedings By: Katie Rubino Recently at the end of April, the Supreme Court denied […]
May 10, 2019
Caldwell IP Law Making Health and Fitness a Priority: Equinox Memberships for All Employees By: Emily Gaukstern Employee health and wellness is a priority […]
May 6, 2019
CAFC Affirms Nonobviousness of Vitamin B12 and Folate Administration Prior to Chemotherapy By: Katie Rubino On April 26, 2019, the Court of Appeals for the […]
April 22, 2019
IPR Incomplete: PTAB Fails to Initiate Indefinite IPR Petition By: Katie Rubino Recently on March 6, 2019 the Patent Trial and Appeal Board (PTAB) issued […]
April 8, 2019
PTAB Enacts New Pilot Program on Motions to Amend During Post Grant Proceedings By: Katie Rubino Recently the Patent Trial and Appeal Board (PTAB) instituted […]